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DENDRITIKUS SEJT ALTÍPUSOK EGYÜTTMŰKÖDÉSE FIZIOLÓGIÁS ÉS 
KÓROS ÁLLAPOTBAN 
 
The major goal of the project was the systematic analysis of dendritic cell (DC) activation by ligands 
of various pattern recognition receptors (PRR) that involve Toll-like receptor (TLR), Nod-like receptor 
(NLR) and RIG-like receptor (RLR) family molecular sensors. These receptors exhibit overlapping 
ligand specificities and show typical localization patterns in various cell types. TLR are integrated to 
cell- or vesicular membranes, whereas RLR and NLR proteins reside in the cytosol. Recent studies 
revealed the subtype and subset specific expression of these PRR family members in human DC 
subtypes and subsets. In this project we focused to:  
 
• studying the functional role of these PRR in the activation of the previously identified and 
characterized humun monocyte-derived CD14lowDC-SIGN+CD1a-PPARγ+ (CD1a+) and the 
CD14-DC-SIGN+CD1a+PPARγ- (CD1a-) monocyte-derived DC subsets;  
• investigate the collaboration of these receptors in conventional and plasmacytoid DC 
subtypes.  
 
1. Collaboration of vesicular TLR and intracellular RLR in conventional DC 
 
1.1 Activation of moDC subsets by TLR ligands 
Conventional DC express vesicular TLR3, TLR4 and the structurally related TLR7/8 receptors. To 
assess the response of CD1a- and CD1a+ monocyte-derived DC (moDC) to ligands targeting these 
receptors (polyI:C, LPS, CL075, respectively) we studied the phenotypic changes and cytokine 
secretion of activated DC derived from 5 – 7 healthy blood donors. We found statistically significant 
differences in the rate of activation monitored by the activation molecule CD83 and the chemokine 
receptor CCR7, as well as by the secretion of the inflammatory cytokines TNF-α, IL-6, IL-10 and IL-
12. The T-cell polarizing cytokine IL-12 was predominantly produced by CD1a+, whereas IL-10 was 
produced by CD1a- cells indicating the inflammatory and regulatory functions of these subsets. To 
analyze the effect of differential TLR expression in these subsets we compared mRNA expression 
levels in these isolated DC subsets. We found that TLR3 and TLR7/8 are expressed at higher levels in 
CD1a+ cells than in the CD1a- ones, but TLR4 was expressed at higher levels in CD1a- cells. 
Furthermore, the response to LPS required DC-conditioned medium and showed high variations 
among the tested donors. These results suggested complex LPS-mediated signaling in DC subsets and 
prompted us to study additional factors involved in LPS-mediated stimulation of CD1a- and CD1a+ 
DCs. To this end we studied the dependence of DC activation on the presence of membrane bound and 
soluble CD14 (sCD14) protein that id preferentially expressed by monocytes, to a lower extent by 
CD1a- DC and not by CD1a+ DC. Both proteins bind LPS in a molecular complex with the MD2 
protein, when transferred by the LPS binding protein (LBP). Soluble CD14 was detected in the 
supernatants of both moDC subsets but was shown to be released predominantly by CD1a- cells in line 
with the low CD14 positivity of this subset. As sCD14 redirects LPS from cells to the extracellular 
spane, the decreased activation of CD1a- cells by LPS may be caused by this phenotypic difference.  
 
These results were summarized in the diploma work of Varga Rita Éva awarded by the prizes TDK II. 
2008, OTDK I. 2009. 
 
These results altogether revealed that CD1a- and CD1a+ cells responded differentially to various 
TLR signals. Furthermore, LPS-mediated activation of DC subsets depends on additional extra- 
and/or intracellular regulatory factors. Describing the underlying mechanisms involved in signal 
transduction of TLR4-mediated signals in these functionally distinct DC subsets is still in progress.   
 
1.2. LPS signaling in monocyte-derived dendritic cell subsets 
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Our gene array studies focusing to TLR signaling pathways revealed that the expression 
pattern of the tested genes in resting DC were higher in CD1a- cells than in their CD1a+ 
counterpart. However, TLR3 receptor expression but not that of TLR4 and TLR7/8 was up-
regulated by its ligand-induced activation suggesting that TLR-mediated signaling is not 
directly linked to the more inflammatory nature of the CD1a+ subset. To uncover the 
molecular background of differential activation and inflammatory potential of CD1a- and 
CD1a+ DC we sought to perform global gene expression profiling and identified the genes 
involved in the different TLR signaling pathways. Our results indicated marked differences 
between the signaling pathways involved in TLR4- and TLR3-mediated signal transduction 
and identified the cytosolic sensor melanoma differentiation associated gene 5 (MDA5), which 
signals through interferon regulatory factor 3 (IRF3) and leads to type I interferon secretion in CD1a+ 
DC. Our data also demonstrated the involvement of different sets of genes induced by LPS and 
polyI:C, targeting TLR4 and TLR3, respectively. 
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Figure 1 Dendritic cells isolated from donors D1, D3, D4 were sorted for CD1a- and CD1a+ fractions 
and gene expression profiles were generated by using the Illumina platform1. The results are shown as 
relative ratios of expression levels in CD1a+ vs CD1a- cells. Red color identifies up-regulation, green 
color indicates down-regulation as compared to resting DC. 
 
1.3. Role of RLR family helicases in type I interferon production by a subset of 
monocyte-derived dendritic cells  
To search for mechanisms that support inflammatory DC activation we compared the  
expression levels of the RLR family retinoic acid-induced gene I (RIG-I) and MDA5 
helicases as a result of activation by various signals and monitored the expression and 
activation of the signaling pathways, connected to these sensors, in CD1a- and CD1a+ cells. 
Cytosolic RLR are PRR involved in interferon production and anti-viral immunity. Functional 
comparison of the previously identified CD14-DC-SIGN+PPARγlowCD1a+ and CD14lowDC-
SIGN+PPARγhighCD1a- human moDC revealed that i) RIG-I and MDA5 gene and protein 
expressions are higher in CD1a+ moDC than in their CD1a- counterpart and components of 
the RLR-related signalling pathway are expressed preferentially in the CD1a+ subset. ii) The 
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RLR-coupled signalling pathway is more active in the CD1a+ subset as compared to CD1a- 
cells and results in the production of IFNβ in an IRF3-dependent manner. iii) We also 
provided the first evidence that the type I interferon response in human moDC is primarily 
mediated by the RLR sensor system, whereas the regulation of pro-inflammatory cytokine 
production is under the control of the TLR3-NF-κB pathway that challenges the current 
paradigm concerning the collaborative or dichotomical regulation of type I interferon and 
inflammatory cytokine responses in human DC. iv) The increased activity of the RLR – IRF3 
– IFNβ signalling pathway was shown to result in efficient priming of naïve CD8+ T 
lymphocytes by the CD1a+ subset and silencing of RIG-I/MDA5 abrogated this effect. 
Furthermore, the presence of RIG-I/MDA5 positive cells with DC morphology in tonsil, 
reactive lymph nodes (LN) and in adult respiratory distress syndrome caused by A(H1N1)-
2009 influenza virus infection verified the in vivo importance of CD1a+ RIG-I and MDA5 
expressing DC. These findings not only describe the underlying mechanism of IFNβ 
production in two moDC subsets with complementary functions but also identify them as 
possible targets of modulating immune pathology or improving the efficacy of prophylactic 
and/or therapeutic vaccines against intracellular pathogens or tumors. As a summary our 
results identify the CD1a- and CD1a+ DC subsets with complementary functions against 
viruses as potential targets for modulating immune responses2.  
 
In 2007 – 2011 these results were presented at international meetings in 7 lectures and 8 
posters by Attila Szabó, a pre-doctoral fellow.  His poster presented at the Semmelweis PhD 
Scientific Days was awarded as the Best Poster Presentation of the Section, 2009). Two 
lectures were presented by Krisztián Bene, the MSc student of Attila Szabó at Student 
Conferences in 2009 and 2010. 
 
1.4. Human inhibitory complement receptors are part of the TLR4 receptor complex 
Complement inIn a scientific collaboration with István Andó (Biological Research Centre, 
Szeged) we showed that the composition of the LPS complex is reorganized upon monocyte 
to DC transition, and two complement inhibitory membrane proteins, CD55 and CD59 are 
also acting ascomponents of the LPS receptor complex in human moDC. Down regulation of 
these proteins by small interfering RNA (siRNA), or inactivating these receptors by 
neutralizing monoclonal antibodies (mAb) inhibited DC activation as monitored by CD83 and 
CCR7 expression, inflammatory cytokine secretion tested by ELISA and chemokine-induced 
DC migration.  
 
These results were summarized in the diploma work of Edit Posta, a medical student and 
awarded by the prizes TDK I. 2009, OTDK V. 2009, OTDK VI. 2011.  
 
1.5. Early activation of monocyte-derived dendritic cells triggers inhibitory 
mechanisms 
We have shown that early activation of developing moDC triggers both immediate and 
persisting inhibitory mechanisms leading to aborted cytokine production and a non-migratory 
phenotype. Dendritic cells migrate towards lymphoid tissues in response to activation signals, 
whereas monocytes are able to enter inflamed tissues and give rise to newly generated 
inflammatory DC. These DC can participate in local immune responses or may differentiate 
towards migratory DC that maintain homeostatic naïve T cell activation. Long-term activation 
of DC however, has been associated with impaired functionality of these cells. How moDC 
developing in inflamed tissues avoid functional exhaustion due to persistent stimulatory 
signals is a question yet to be solved. We have shown that early activation of developing 
moDC leads to transient cytokine production accompanied by the up-regulation of the 
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inhibitory factors SOCS1, IL-10, STAT-3, miR146a and CD150 (SLAM), which conferred 
short term inhibitory effects on cytokine production but did not lead to persistent DC 
inactivation. The transient cytokine production was accompanied by IRAK-1 downregulation, 
inactivation of MyD88-dependent pathways and the inability of the cells to respond to further 
TLR ligation with IL-12 or TNF-α production. Furthermore, early activation during moDC 
differentiation was not accompanied by migratory DC differentiation, as reflected by the lack 
of CCR7 induction and the maintenance of CCR5 expression. Stimulation of monocytic DC 
precursors may thus lead to the rapid down-regulation of effector functions and the 
preservation of a tissue resident non-migratory phenotype.3 
 
These results were presented at 3 international meetings and at Student Conference (2008, 
2009) by Tünde Fekete, PhD student. 
 
 
2.Collaboration of vesicular and cytosolic PRR and other factors in activation of 
plasmacytoid and conventional dendritic cells 
 
2.1. TLR and RLR cross-talk in pDC 
Plasmacytoid DC express vesicular TLR7 and TLR9 in combination with the cytosolic 
sensors RIG-I and MDA5. Specific ligands of all these receptors trigger signaling pathways 
resulting in type I interferon (IFN) production. We addressed the question, which receptor(s) is/are 
responsible for the high amounts of IFNα secretion by pDC, also referred to as natural interferon 
producing cells (NIPC). Studies on pDC are hampered by their scarcity, short survival time in 
culture and difficulties to collect them. Using primary pDC available at limited amounts, and 
leukemic pDC cells (pDC-L) we provided ample evidence that the malignant cells isolated from 
bone marrow samples of a patient suffering from pDC leukemia are suitable for pDC 
research. Phenotypic maturation and cytokine secretion of pDC-L cells following TLR9 
ligand (type A and type B CpG) or TLR7 ligand (imiquimod) stimulation were identical with 
those described for primary pDCs. Although pDC-L cells lack the ability to release IFNα due 
to the side effect of cryopreservation, the IFN signaling pathway was shown to be functional 
in them and they are able to activate T-cells. The expression of cytosolic RLR RNA receptors 
is established in conventional DC, but their expression and function in pDCs has not been 
characterized sofar. We showed that both pDC-L cells and primary pDCs express RIG-I and 
MDA5 under steady-state conditions at similar low levels, whereas the expression of these 
RLR is dramatically up-regulated upon stimulation with imiquimod or type A CpG. We also 
demonstrated for the firs time that TLR7-mediated signals efficiently block the expression of 
type I IFN genes induced by RIG-I/MDA5 ligands and thus regulate RLR functions through 
concomitantly switching on the ubiquitin-like IFN stimulated gene 15 (ISG15)-mediated 
inhibitory pathway to keep the inflammatory responses under control. The role of this 
regulation in the pathology of pDC leukemia, in virus induced pDCs stimulation and in 
autoimmune diseases remains to be explored4. 
 
These results show that the expression of various combinations of TLR and RLR family 
members by itself does not correlate with their functional activity that seems to be under tight 
control to prevent exacerbated inflammation. 
 
2.2. Activation of dendritic cells by the coordinate action of NOD2 and inferferon-γ 
Interferon-gamma (IFNγ) is produced by NK- and inflammatory Th1 cells and acts as an 
autocrine master cytokine driving inflammatory Th1 polarization. IFNγ triggers cells 
expressing type II interferon receptors (IFNRII) and signals through the Jak1 – Stat1 pathway. 
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To assess the interplay of MDP-induced NLR- and IFNγ cytokine-mediated signaling in 
moDC we exposed the cells to MDP in the presence or absence of IFNγ and monitored the 
expression of NLR family genes and proteins (Nalp3, NOD2 and caspase-1) and the 
functional characteristics of the activated cells. Our experiments showed that MDP alone has 
no effect on the expression levels of NOD2, Nalp3 or caspase-1, but results in IκB 
phosphorylation and activation of the NFκB pathway one hour after stimulation. IFNγ up-
regulates NOD2 and caspase-1 mRNA, but the expression of Nalp3 mRNA and NOD2 
protein requires both IFNγ- and MDP-mediated signaling suggesting the synergistic effects of 
the two pathways. Expression of the CD83 activation marker in the plasma membrane and the 
production of high levels of inflammatory citokines (TNF-α, IL-6, IL-1β, IL-8, IL-12) also 
was dependent on the presence of both ligands. The highest levels of biologically active 
cytokines were secreted when the cells were pre-treated by IFNγ followed by MDP 
stimulation as compared to simultaneous activation by IFNγ and MDP. These results 
demonstrate that the secretion of biologically active IL-1β requires the collaboration of the 
NLR sensor system with exogenous IFNγ that sensitizes DC to MDP, a known ligand of 
Nod2.   
It has previously been described in resting murine bone marrow macrophages that Nod2 co-
localizes with actin in the perinuclear region, but IFNγ is able to induce its dissociation from 
the actin cytoskeleton. These data suggest that IFNγ is able to prime cells for Nod2 
redistribution to the cytosol and prompted us to test the role of IFNγ on the expression of 
components of the Nod2-signalosome. Our results indicated that in moDC IFNγ not only 
triggers NOD2 but also induces caspase-1 expression and thus allows the production of 
biologically active IL-1β. Furthermore, MDP was shown to trigger rapid modification of 
IKKγ/NEMO and degradation of phospho-IκB-α, however these events were not sufficient to 
induce enhanced cell surface expression of CD83 and the secretion of cytokine secretion. 
These functional changes required the interplay of MDP and IFNγ. To demonstrate the 
contribution of the Nod2-signalosome to inflammatory cytokine production we used the 
siRNA approach. Silencing of the Nod2 gene, the receptor component of the signallosome 
was performed by a mixture of specific and control siRNA. When differentiating DC were 
treated by Nod2-specific siRNA and were stimulated by MDP + IFNγ, a 60+10 % decrease in 
Nod2 gene expression was shown as compared to control siRNA, while had marginal effect 
on electroporated cells indicating that down-regulation of NOD2 mRNA affected RIP2 and 
IκB expression. As Nod2 binds to ubiquitinylated RIP2, an obligate component of the Nod2 
signalosome to induce NF-κB activation, we suggest that NOD2 expression regulates the 
amount of NOD2:RIP2 complexes, lysine-63 (K63) polyubiquitination of lysine-285 on 
IKKγ/NEMO and consequently IκB degradation. As a consequence, the levels of NF-κB 
induced cytokines are decreased as a compared to the control samples where NOD2 
expression is high. Thus NOD2 gene and protein expression has a critical role in regulating 
RIP2 – IKKγ/NEMO-mediated activation of the NF-κB pathway, while caspase-1 activity is 
ensured by IFNγ.     
 
Based on these results we suggest that Nod2-mediated NFκB signaling and the Jak-Stat 
pathway used by IFNγ is linked in moDC and may have an impact on inducing inflammatory 
T cell responses.   
 
3. The effect of apoptotic cell internalization on dendritic cell functions 
 
The means how phagocytes handle apoptotic cells has a great impact on the outcome of 
immune responses. Here we show that phagocytosis of apoptotic neutrophils by human moDC 
is slow and less efficient than that of macrophages, and CD1a- DC are more active in the 
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engulfment of apoptotic neutrophils than CD1a+ DC. Blocking DC-SIGN function partially 
interferes with the uptake of apoptotic cells and long term interaction of apoptotic neutrophils 
with DC make them prone to pro-inflammatory cytokine responses. Engulfment of apoptotic 
cells sensitizes CD1a- DC for high IL-8, TNF-α, IL-6, and CD1a+ cells for IL-12 and IL-10 
cytokine secretion elicited by additional inflammatory stimuli, which also result in 
polarization of autologous T lymphocytes to Th1 effector cells. However, as a result of 
PPARγ activation by rosiglitasone, the inflammatory response of CD1a- DC with high PPARγ 
expression and their capacity to trigger Th1 cell activation is down modulated. These results 
demonstrate that DC are able to respond to apoptotic neutrophils with inflammatory cytokine 
and T-cell responses in a subtype specific manner that can be modulated by the anti-
inflammatory effects of PPARγ.5 
Glucocorticoids are powerful anti-inflammatory compounds inhibiting inflammatory cell 
recruitment and production of pro-inflammatory cytokines. As we found that DC, the key-
players of T cell priming and polarization respond to allogeneic apoptotic neutrophils with 
proinflammatory cytokine release and Th1 cell activation, we also tested the the capacity of 
moDC to engulf apoptotic cells and up-regulate genes of the apopto-phagocytic system. This 
gene expression pattern was reprogrammed when moDC differentiation took place in the 
presence of the synthetic glucocorticoid dexamethasone (Dex), which increased the 
expression of phagocytosis receptors MERTK and CD14, the bridging molecule C1QA, 
DNASE2 and the adenosine A3 receptor (ADORA3). The increased phagocytosis was 
attenuated by the addition of ADORA3 antagonist and could not be observed when bone 
marrow-derived DC of ADORA3 knockout mice were treated with Dex. The glucocorticoid 
treated human moDC loaded with apoptotic neutrophils secreted, in response to LPS and 
IFNγ, the inflammatory cytokine TNF-α. Furthermore, Dex-treated moDC could activate 
autologous T lymphocytes toward Th1 effector cells and this was enhanced by their exposure 
to allogeneic apoptotic neutrophils.6 
 
4. Role of ion channels in dendritic cell functions 
 
It has been reported that various voltage gated sodium channel (VGSCs) antagonists are able 
to influence the activation of lymphocytes, modify volume regulation, migration and 
apoptosis and impair phagocytosis and inflammatory responses of macrophages. However, 
the function of VGSCs in immune cells is still elusive. Previously we characterized a novel 
VGSC Nav1.7 channel expressed by monocyte-derived DCs and demonstrated a 
developmental switch of the Nav1.7 and VGPC Kv1.3 expression and function in the course 
of in vitro monocyte-derived DC maturation.7 Expression of CD1a protein defines a human 
moDC subset with unique functional activities. We aimed to study the expression of the 
Nav1.7 sodium channel and the functional consequences of its activity in CD1a- and CD1a+ 
DC. Single-cell electrophysiology (patch-clamp) and Q-PCR experiments performed on 
sorted CD1a− and CD1a+  resting DC showed that the frequency of cells expressing Na+ 
current, current density and the relative expression of the SCN9A gene encoding Nav1.7 were 
significantly higher in CD1a+ cells than in their CD1a− counterparts. We also showed that the 
presence and activity of active Nav1.7 channels results in a depolarized resting membrane 
potential (−8.7±1.5 mV) in CD1a+ IDC as compared to CD1a− cells lacking Nav1.7 (−47±6.2 
mV). Stimulation of DC by inflammatory signals or by increased intracellular Ca2+ levels 
resulted in reduced Nav1.7 expression. Silencing of the SCN9A gene shifted the membrane 
potential to a hyperpolarizing direction in CD1a+ IDC resulting in decreased cell migration, 
whereas pharmacological inhibition of Nav1.7 by tetrodotoxin sensitized the cells for 
activation signals. Fine tuning of IDC functions by a voltage-gated sodium channel emerges 
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as a new regulatory mechanism modulating the migration and cytokine responses of these DC 
subsets.8  
In line with these studies, the importance and regulatory function of other membrane channels 
in DC and other immune cells has also been described.9 10 
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